Genital Warts Treatment Market being driven by an increase in the prevalence of warts and HPV infections

 Genital Warts Therapeutics Market: Introduction

  • The human papillomavirus causes genital warts, which are a common sexually transmitted infection (HPV). At some point in their lives, nearly all sexually active people are likely to become infected with at least one type of human papillomavirus (HPV), the virus that causes genital warts. Some genital HPV strains can cause genital warts, while others can cause cancer.

Key Drivers and Restraints of Global Genital Warts Treatment Market

  • The market is being driven by an increase in the prevalence of warts and HPV infections. People who have a weakened immune system as a result of an organ transplant, serious diseases such as cancer or AIDS, or atopic diseases are more likely to develop warts. As the number of people diagnosed with cancer rises, so does the prevalence of warts, driving the market. According to the Anal Cancer Foundation, an estimated 14 million people in the United States are infected with HPV each year. According to the Centers for Disease Control and Prevention, approximately 340,000 to 360,000 women and men in the United States are affected by genital warts caused by HPV each year, and it typically develops between 2 and 3 months after the HPV infection.
  • Wart recurrence raises the demand for treatment. Warts can be treated in a variety of ways. Recurrences, on the other hand, are common. A large number of cases of genital warts do not respond to treatment and frequently recur, especially when infections from HPV have a long incubation period.
  • However, the market may be hampered by a low diagnostic rate due to a lack of awareness. The prevalence of warts is higher in the general population; however, the diagnosis rate in patients is low. According to the Health Protection Report, the rate of genital warts diagnosis among girls aged 15 to 17 years attending sexual health services in England in 2018 decreased by 92% compared to 2014. Furthermore, existing treatment procedures are frequently painful or invasive, can result in undesirable outcomes such as scarring or dyspigmentation, and frequently necessitate repeat visits. As a result, the diagnostic rate falls, which is likely to restrain genital warts treatment market.

  • North America is estimated to dominate the Global Genital Warts Treatment Market

    • The global genital warts therapeutics market can be divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
    • North America led the genital warts therapeutics market in terms of revenue, followed by Europe. The region's market is expected to be driven by well-established health care infrastructure, early adoption of advanced products, and the presence of key players. Furthermore, leading players' emphasis on R&D is expected to boost the market.
    • However, the market in Asia Pacific is expected to grow at a significant CAGR during the forecast period due to a significantly large and growing patient population. The region's market is expected to be driven in the near future by improvements in health care infrastructure and an increase in the prevalence of warts. According to an article published in the journal Infectious Agents and Cancer, a study conducted in the Philippines from 2011 to 2012 found that the prevalence of genital warts was 4.78 percent; the prevalence was higher among men than women across all age groups.

Comments

Post a Comment

Popular posts from this blog

One of the primary factors driving the Worldwide Frosting and Icing Market is the rising demand for cakes and pastries.

Image
  Market Dynamics The increased demand for cakes and pastries is one of the key reasons driving the global frosting and icing market . According to Agriculture and Agri-Food Canada, the value of cakes sold in the United Kingdom increased by an average of 2% every year from 2012 to 2017, outpacing the CAGR by 1.5 percent (2007-2012). Furthermore, an increase in the number of bakeries as a result of increased urbanisation and rising income, which leads to a burgeoning food sector, is fueling the expansion of the frosting and icing market. In 2015, India's food processing business was valued at US$ 258 billion, according to the India Brand Equity Foundation (IBEF), ranking fifth in terms of consumption, output, and exports. Health issues, such as increased obesity, are, however, restraining market growth. In 2017, 36.5 percent of adults in the United States were obese, according to the Centers for Disease Control and Prevention (CDC), which impeded market expansion. To tackle this, a ...
Read more

Orthopedic Power Tools Market predicted to be growing at a CAGR of 3.50 percent over the forecast period (2020-2027)

Image
Various orthopaedic illnesses in the musculoskeletal systems, such as musculoskeletal trauma, spine diseases, musculoskeletal injuries, and infections, are treated by orthopaedics. Orthopedic power tools are lightweight, user-friendly, and easy to handle when performing orthopaedic surgery when compared to traditional heavy orthopaedic tools. Electric powered orthopaedic tools, battery operated power systems, and pneumatic power tools are the three types of orthopaedic power tools. In 2020, the global orthopaedic power tools market is predicted to be worth US$ 943.8 million, growing at a CAGR of 3.50 percent over the forecast period (2020-2027). One of the reasons predicted to drive market expansion during the forecast period is the rising frequency of spinal injuries. According to a report issued by the National Spinal Cord Injury Statistical Center in 2018, the incidence of spinal cord injury in the United States is roughly 54 instances per one million individuals, with around 17,70...
Read more

The Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market will continue to increase as the number of ambulatory individuals seeking treatment for skin and skin structure infections rises

Image
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are infections of the epidermis, dermis, and subcutaneous tissues that affect the skin and soft tissues. ABSSSI is defined by the US FDA as lesions having cellulitis/erysipelas, wound infections, and large cutaneous abscesses with a surface area of at least 75 cm2. ABSSSI is caused by pathogens such as Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, E. coli, Enterococcus faecalis, and Pseudomonas aeruginosa. The rising incidence of drug-resistant strains, particularly in Staphylococcus spp. and Enterococcus spp., makes this infection challenging to treat. The ABSSSI market is predicted to grow at a steady pace, thanks to an increasing number of patients suffering from these conditions and a significant number of pipeline treatments expected to be authorised during the forecast period. Acute Bacterial Skin and Skin Structure Infections (ABSSSI...
Read more